| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/14/1995 | WO1995024214A1 Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome |
| 09/14/1995 | WO1995021246A3 Operating procedure for the production of viruses and virus resistant cells for the testing of anti-viral substances using laboratory animals |
| 09/14/1995 | DE4407489A1 Vakzine zur Prävention von Respirations- und Reproduktionserkrankungen des Schweines Vaccine for the prevention of respiratory and reproductive diseases of the pig |
| 09/14/1995 | CA2185097A1 Activating virus |
| 09/14/1995 | CA2184833A1 Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome |
| 09/13/1995 | EP0670905A1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
| 09/12/1995 | US5449614 Recombinant retroviruses with amphotropic and ecotropic host ranges |
| 09/12/1995 | US5449608 Detection |
| 09/08/1995 | WO1995023867A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
| 09/08/1995 | WO1995023866A1 Vector for liver-specific gene therapy |
| 09/08/1995 | WO1995023848A1 Selective virus culture |
| 09/08/1995 | WO1995023846A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins |
| 09/08/1995 | WO1995019429A3 Method and reagent for inhibiting hepatitis c virus replication |
| 09/08/1995 | CA2184354A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins |
| 09/08/1995 | CA2184113A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
| 09/06/1995 | EP0669987A1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 09/06/1995 | EP0669930A1 Cellular genes encoding retinoblastoma-associated proteins |
| 09/06/1995 | EP0151579B1 Method and products for detection of human t cell leukemia virus |
| 09/05/1995 | US5447915 Terminally blocked antiviral peptides |
| 09/05/1995 | US5447861 Continuous mammalian cell lines having monocyte/macrophage characteristics and their establishment in vitro |
| 09/05/1995 | US5447859 Method for the purification or removal of retroviruses using sulfated cellulose |
| 09/05/1995 | US5447836 Bacterial detection by phage transduction of ice nucleation and other phenotypes |
| 08/31/1995 | WO1995023215A1 A process for producing viruses, viral proteins and recombinant proteins |
| 08/31/1995 | WO1995022978A1 Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 08/30/1995 | EP0669133A1 Paramunity inducer based ou combinations of poxvirus components, process to prepore it and its use as medicament |
| 08/24/1995 | WO1995022626A1 Human papilloma virus detection in a nucleic acid amplification process using general primers |
| 08/24/1995 | WO1995022617A1 Host-vector system for use in gene therapy |
| 08/24/1995 | WO1995022616A1 Animal model of the alzheimer disease, preparation and utilisations |
| 08/24/1995 | WO1995022607A1 Recombinant equine herpesviruses |
| 08/24/1995 | CA2182880A1 Recombinant equine herpesviruses |
| 08/24/1995 | CA2182724A1 Animal model of the alzheimer disease, preparation and utilisations |
| 08/23/1995 | EP0667912A1 Defective adenovirus vectors and use thereof in gene therapy |
| 08/23/1995 | EP0252962B1 Regulating retroviral replication, infection, and pathogenesis |
| 08/22/1995 | US5443982 Continuous avian hepatocellular carcinoma cell line containing infectious laryngotracheitis virus |
| 08/22/1995 | US5443969 In vivo system for expression and packaging a genetic engineered single stranded RNA of unlimited length into pseudovirus particles comprised of plant viral coat proteins; storage stability, ribonuclease resistant |
| 08/22/1995 | US5443828 AIDS vaccine |
| 08/17/1995 | WO1995021922A2 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
| 08/17/1995 | WO1995021912A1 Non-pathogenic strains of hiv-1 |
| 08/17/1995 | WO1995021632A1 Process for inactivating thermolabile viruses in biological material while preserving collagen properties |
| 08/17/1995 | WO1995007994A3 Recombinant alphavirus vectors |
| 08/17/1995 | CA2183154A1 Non-pathogenic strains of hiv-1 |
| 08/17/1995 | CA2166313A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
| 08/16/1995 | EP0666755A1 Inhibitiion of retrovirus infection |
| 08/16/1995 | EP0666751A1 Hepatitis a virus vaccines |
| 08/15/1995 | US5441703 Having conicoidal interior contour which homogeneously widens flow of reactant gases |
| 08/10/1995 | WO1995021261A1 Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof |
| 08/10/1995 | WO1995021256A1 Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same |
| 08/10/1995 | WO1995021246A2 Operating procedure for the production of viruses and virus resistant cells for the testing of anti-viral substances using laboratory animals |
| 08/10/1995 | WO1995020961A1 Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light |
| 08/10/1995 | CA2182708A1 Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof |
| 08/09/1995 | EP0490972B1 Recombinant negative strand rna virus expression systems and vaccines |
| 08/08/1995 | US5439809 Non-infectious HIV particles lacking long terminal repeats |
| 08/08/1995 | CA1336581C Aloe composition and uses thereof |
| 08/05/1995 | CA2141907A1 Virus msrvl and pathogen agent and/or msrv2 associated with multiple sclerosis, their nucleic constituants and their applications |
| 08/03/1995 | WO1995020672A1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies |
| 08/03/1995 | WO1995020671A1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof |
| 08/03/1995 | WO1995020659A1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM |
| 08/03/1995 | WO1995020318A1 Ancient organisms |
| 08/03/1995 | WO1995012660A3 Recombinant p53 adenovirus methods and compositions |
| 08/03/1995 | CA2182380A1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies |
| 08/03/1995 | CA2182269A1 Ancient organisms |
| 08/03/1995 | CA2181602A1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof |
| 08/01/1995 | US5437951 A genetic construct comprising a PAPILLOMAVIRUS L1 gene; vaccines, diagnostic kits; genetic engineering |
| 07/26/1995 | EP0664337A1 Methods for utilizing cell lines which lack human class II histocompatibility antigens |
| 07/26/1995 | EP0663953A1 Phagemids coexpressing a surface receptor and a surface heterologous protein |
| 07/25/1995 | US5436146 Helper-free stocks of recombinant adeno-associated virus vectors |
| 07/25/1995 | US5436005 Low virulence infectiouns laryngotracheitis (ILT) virus for vaccinating birds |
| 07/25/1995 | CA1336407C Prevention and treatment of retroviral disease |
| 07/20/1995 | WO1995019429A2 Method and reagent for inhibiting hepatitis c virus replication |
| 07/20/1995 | WO1995019427A1 Purification of retroviral vectors |
| 07/20/1995 | CA2181066A1 Purification of retroviral vectors |
| 07/20/1995 | CA2180740A1 Method and reagent for inhibiting hepatitis c virus replication |
| 07/19/1995 | EP0663403A1 Vector vaccines of bovine herpesvirus I |
| 07/19/1995 | EP0332677B1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 07/13/1995 | WO1995018852A1 Herpesvirus replication defective mutants |
| 07/13/1995 | WO1995018529A1 Peracetic acid sterilization |
| 07/13/1995 | CA2180551A1 Herpesvirus replication defective mutants |
| 07/12/1995 | EP0662139A1 Recombinant retroviral vector against felv and/or fiv |
| 07/12/1995 | EP0662133A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 07/12/1995 | EP0662132A1 Self-assembling recombinant papillomavirus capsid proteins |
| 07/11/1995 | US5432018 Peptide library and screening systems |
| 07/06/1995 | WO1995018223A1 Gene expression control |
| 07/06/1995 | WO1995012682A3 Viral vector with bovine viral diarrhea virus (bvdv) antigens |
| 07/06/1995 | WO1995011984A3 Recombinant adenoviral vector and methods of use |
| 06/29/1995 | WO1995017503A1 Thermostable varicella zoster virus |
| 06/29/1995 | WO1995017415A1 In vitro phage lambda dna packaging extract |
| 06/29/1995 | CA2177060A1 Thermostable varicella zoster virus |
| 06/28/1995 | EP0659885A1 Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity |
| 06/27/1995 | US5427908 Transforming cell with filamentous bacteriophage expression vector, culturing for expression and assembly of particle with antibody Fab fragment on coat, selecting encoding particle by binding to specific ligand, removing nonbinding particles |
| 06/27/1995 | US5427791 Embryonal vaccine against Newcastle disease |
| 06/22/1995 | WO1995007987A3 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
| 06/22/1995 | WO1995003407A3 Oligonucleotides with activity against human immunodeficiency virus |
| 06/21/1995 | EP0658623A2 Attenuated herpesviruses, herpesviruses which include foreign DNA encoding an amino acid sequence and vaccines containing same |
| 06/21/1995 | EP0658196A1 GENE INSERTION BY DIRECT LIGATION $i(IN VITRO) |
| 06/21/1995 | EP0658119A1 New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate |
| 06/20/1995 | US5426028 Testing sample of peripheral mononuclear cell, evaluating sample for CD11b, CD38 and antigen HLA-DR, by combining it with an immunophenotypic panel comprising atleast one antibody and analyzing |
| 06/15/1995 | WO1995016051A2 Methods and compositions for the suppression of neu mediated transformation |
| 06/15/1995 | WO1995016048A2 Recombinant protein production in bovine adenovirus expression vector system |
| 06/15/1995 | WO1995016027A1 Method of selecting specific bacteriophages |
| 06/15/1995 | WO1995014100A3 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |